Renalytix AI plc, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that the Centers for Medicare and Medicaid Services has released the Final 2020 Clinical Laboratory Fee Schedule and has set a national price for the Company’s KidneyIntelX™ test.
December 3, 2019
· 2 min read